Skip to content. | Skip to navigation
NICE has published final draft guidance which recommends fremanezumab (also called Ajovy and made by Teva Pharmaceuticals) for preventing chronic migraine.
NICE says 10,000 people could benefit from the “cost-effective” drug. More....
